The present invention relates to compounds of formula (I) useful in treating Alzheimer's disease and other similar diseases. These compounds include inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal. The compounds of the invention are also useful in pharmaceutical compositions and methods of treatment to reduce A beta peptid e formation.
(HETERO) ARYLAMIDE 2-HYDROXY-3-DIAMINOALKANES FOR USE IN THETREATMENT OF ALZHEIMER~S DISEASE